| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/02/2023 | 14.65% | Raymond James | $255 → $260 | Maintains | Outperform |
| 10/17/2023 | 25.67% | Truist Securities | $275 → $285 | Maintains | Buy |
| 10/09/2023 | 21.26% | B of A Securities | $267 → $275 | Maintains | Buy |
| 09/14/2023 | 26.99% | Argus Research | → $288 | Initiates Coverage On | → Buy |
| 09/07/2023 | 21.26% | Truist Securities | $270 → $275 | Maintains | Buy |
| 08/04/2023 | 4.95% | BMO Capital | $229 → $238 | Maintains | Market Perform |
| 08/03/2023 | 14.65% | JP Morgan | $225 → $260 | Maintains | Overweight |
| 08/03/2023 | 12% | Baird | $250 → $254 | Maintains | Outperform |
| 08/03/2023 | 12.44% | Raymond James | $225 → $255 | Maintains | Outperform |
| 08/03/2023 | 19.06% | Truist Securities | $260 → $270 | Maintains | Buy |
| 08/03/2023 | -3.43% | Morgan Stanley | $201 → $219 | Maintains | Equal-Weight |
| 08/03/2023 | 10.24% | RBC Capital | → $250 | Reiterates | Outperform → Outperform |
| 08/03/2023 | 21.26% | Barclays | $250 → $275 | Maintains | Overweight |
| 08/02/2023 | 17.73% | B of A Securities | → $267 | Maintains | Buy |
| 07/21/2023 | 5.83% | Goldman Sachs | $215 → $240 | Maintains | Neutral |
| 07/20/2023 | 5.83% | Goldman Sachs | $215 → $240 | Maintains | Neutral |
| 07/19/2023 | 14.65% | Truist Securities | $230 → $260 | Maintains | Buy |
| 07/07/2023 | 10.24% | Barclays | $220 → $250 | Maintains | Overweight |
| 05/11/2023 | 10.24% | RBC Capital | $210 → $250 | Maintains | Outperform |
| 05/04/2023 | -0.79% | JP Morgan | $200 → $225 | Maintains | Overweight |
| 05/04/2023 | -5.2% | BMO Capital | $198 → $215 | Maintains | Market Perform |
| 05/04/2023 | -7.4% | RBC Capital | → $210 | Reiterates | → Outperform |
| 05/04/2023 | 1.42% | Truist Securities | $210 → $230 | Maintains | Buy |
| 05/04/2023 | -11.37% | Morgan Stanley | $186 → $201 | Maintains | Equal-Weight |
| 05/04/2023 | -5.2% | Goldman Sachs | $191 → $215 | Maintains | Neutral |
| 05/04/2023 | 7.15% | B of A Securities | $167 → $243 | Upgrades | Underperform → Buy |
| 05/04/2023 | -0.79% | Baird | $206 → $225 | Maintains | Outperform |
| 03/20/2023 | — | Redburn Partners | Upgrades | Sell → Neutral | |
| 03/15/2023 | -7.4% | RBC Capital | → $210 | Reiterates | → Outperform |
| 03/14/2023 | -17.1% | BMO Capital | $188 → $188 | Maintains | Market Perform |
| 03/06/2023 | -17.54% | Credit Suisse | $165 → $187 | Maintains | Neutral |
| 03/02/2023 | -9.17% | Baird | $201 → $206 | Maintains | Outperform |
| 03/02/2023 | -11.81% | JP Morgan | $195 → $200 | Maintains | Overweight |
| 03/02/2023 | -17.98% | Morgan Stanley | $181 → $186 | Maintains | Overweight |
| 03/02/2023 | -14.02% | Raymond James | $185 → $195 | Maintains | Outperform |
| 03/02/2023 | -17.1% | BMO Capital | $191 → $188 | Maintains | Market Perform |
| 03/01/2023 | -26.36% | B of A Securities | → $167 | Maintains | Underperform |
| 01/11/2023 | — | Redburn Partners | Initiates Coverage On | → Sell | |
| 01/04/2023 | -20.19% | Morgan Stanley | $170 → $181 | Maintains | Equal-Weight |
| 12/02/2022 | -2.99% | Barclays | $200 → $220 | Maintains | Overweight |
| 11/08/2022 | -25.04% | Morgan Stanley | → $170 | Reinstates | → Equal-Weight |
| 11/07/2022 | -18.42% | Raymond James | $215 → $185 | Maintains | Outperform |
| 11/03/2022 | -11.37% | Baird | $220 → $201 | Maintains | Outperform |
| 11/03/2022 | -14.02% | JP Morgan | $220 → $195 | Maintains | Overweight |
| 11/03/2022 | -23.72% | BMO Capital | $184 → $173 | Maintains | Market Perform |
| 11/02/2022 | -7.4% | Truist Securities | $220 → $210 | Maintains | Buy |
| 10/31/2022 | -2.99% | Baird | $220 → $220 | Maintains | Outperform |
| 10/25/2022 | -7.4% | Jefferies | → $210 | Assumes | → Buy |
| 10/24/2022 | -14.02% | Deutsche Bank | $227 → $195 | Maintains | Buy |
| 10/11/2022 | -16.22% | UBS | $206 → $190 | Maintains | Neutral |
| 09/15/2022 | -2.99% | JP Morgan | → $220 | Maintains | Overweight |
| 08/08/2022 | -9.17% | UBS | $190 → $206 | Maintains | Neutral |
| 08/05/2022 | -5.2% | JP Morgan | → $215 | Maintains | Overweight |
| 08/04/2022 | 0.09% | Deutsche Bank | $226 → $227 | Maintains | Buy |
| 08/04/2022 | -2.99% | Baird | $215 → $220 | Maintains | Outperform |
| 08/04/2022 | -11.81% | BMO Capital | $186 → $200 | Maintains | Market Perform |
| 08/04/2022 | -5.2% | Raymond James | $220 → $215 | Maintains | Outperform |
| 08/03/2022 | -2.99% | Truist Securities | $210 → $220 | Maintains | Buy |
| 07/01/2022 | -11.81% | Barclays | $220 → $200 | Maintains | Overweight |
| 06/29/2022 | -7.4% | RBC Capital | $227 → $210 | Maintains | Outperform |
| 06/15/2022 | -5.2% | Baird | → $215 | Maintains | Outperform |
| 05/05/2022 | -7.4% | Truist Securities | $240 → $210 | Maintains | Buy |
| 05/05/2022 | -9.61% | BMO Capital | $225 → $205 | Maintains | Market Perform |
| 05/05/2022 | 0.09% | RBC Capital | $230 → $227 | Maintains | Outperform |
| 05/05/2022 | -0.35% | Deutsche Bank | $255 → $226 | Maintains | Buy |
| 05/05/2022 | -14.02% | Morgan Stanley | $205 → $195 | Maintains | Equal-Weight |
| 05/03/2022 | -0.79% | Baird | $225 → $225 | Maintains | Outperform |
| 04/19/2022 | -5.2% | UBS | $197 → $215 | Maintains | Neutral |
| 04/14/2022 | 1.42% | RBC Capital | $210 → $230 | Maintains | Outperform |
| 04/13/2022 | -0.79% | Baird | $225 → $225 | Maintains | Outperform |
| 03/30/2022 | 12.44% | Deutsche Bank | → $255 | Initiates Coverage On | → Buy |
| 03/21/2022 | -0.79% | Baird | → $225 | Maintains | Outperform |
| 03/18/2022 | 1.42% | Jefferies | $218 → $230 | Maintains | Buy |
| 03/17/2022 | -9.61% | Baird | → $205 | Maintains | Outperform |
| 03/02/2022 | -2.99% | Raymond James | $240 → $220 | Maintains | Outperform |
| 02/25/2022 | -13.13% | UBS | $226 → $197 | Maintains | Neutral |
| 02/24/2022 | -11.81% | BMO Capital | $216 → $200 | Maintains | Market Perform |
| 02/24/2022 | -22.83% | Credit Suisse | $198 → $175 | Maintains | Neutral |
| 02/24/2022 | -11.37% | Morgan Stanley | $237 → $201 | Maintains | Equal-Weight |
| 02/23/2022 | -7.4% | RBC Capital | → $210 | Maintains | Outperform |
| 02/22/2022 | 1.42% | Baird | $230 → $230 | Maintains | Outperform |
| 02/18/2022 | 1.42% | Baird | $230 → $230 | Maintains | Outperform |
| 01/11/2022 | 1.42% | Baird | → $230 | Maintains | Outperform |
| 01/10/2022 | -0.35% | UBS | $224 → $226 | Maintains | Neutral |
| 01/05/2022 | 4.5% | Morgan Stanley | $232 → $237 | Downgrades | Overweight → Equal-Weight |
| 12/14/2021 | 12.44% | RBC Capital | $235 → $255 | Maintains | Outperform |
| 11/08/2021 | -1.23% | UBS | $192 → $224 | Maintains | Neutral |
| 11/05/2021 | 5.83% | Raymond James | $210 → $240 | Maintains | Outperform |
| 11/03/2021 | 10.24% | Truist Securities | $205 → $250 | Maintains | Buy |
| 11/03/2021 | -4.76% | BMO Capital | → $216 | Maintains | Market Perform |
| 11/03/2021 | 7.15% | Baird | → $243 | Maintains | Outperform |
| 09/28/2021 | 3.62% | RBC Capital | $203 → $235 | Maintains | Outperform |
| 09/23/2021 | -1.23% | Morgan Stanley | $207 → $224 | Maintains | Overweight |
| 08/09/2021 | -7.4% | Raymond James | $190 → $210 | Maintains | Outperform |
| 08/05/2021 | -14.02% | BMO Capital | $182 → $195 | Maintains | Market Perform |
| 08/05/2021 | -15.34% | UBS | $188 → $192 | Maintains | Neutral |
| 08/05/2021 | -15.34% | Baird | $192 → $192 | Maintains | Outperform |
| 08/05/2021 | -8.72% | Morgan Stanley | $209 → $207 | Maintains | Overweight |
| 07/21/2021 | -7.84% | Morgan Stanley | $197 → $209 | Maintains | Overweight |
| 05/17/2021 | -19.75% | BMO Capital | → $182 | Maintains | Market Perform |
| 05/06/2021 | -17.54% | UBS | $188 → $187 | Maintains | Neutral |
| 05/06/2021 | -13.13% | Morgan Stanley | $201 → $197 | Maintains | Overweight |
| 05/05/2021 | -15.34% | Baird | → $192 | Maintains | Outperform |
| 05/05/2021 | -20.63% | Credit Suisse | $195 → $180 | Maintains | Neutral |
| 03/22/2021 | -11.37% | Morgan Stanley | $216 → $201 | Maintains | Overweight |
| 03/08/2021 | -13.57% | Deutsche Bank | $192 → $196 | Upgrades | Hold → Buy |
| 03/08/2021 | -16.22% | Raymond James | → $190 | Upgrades | Market Perform → Outperform |
| 03/01/2021 | — | UBS | Upgrades | Sell → Neutral | |
| 02/25/2021 | -5.2% | Truist Securities | $225 → $215 | Maintains | Buy |
| 02/25/2021 | -19.31% | BMO Capital | $196 → $183 | Maintains | Market Perform |
| 02/25/2021 | -4.76% | Morgan Stanley | $237 → $216 | Maintains | Overweight |
| 01/12/2021 | -13.57% | UBS | $177 → $196 | Maintains | Sell |
| 01/06/2021 | 4.5% | Morgan Stanley | $222 → $237 | Maintains | Overweight |
| 12/02/2020 | -2.11% | Morgan Stanley | $217 → $222 | Maintains | Overweight |
| 12/01/2020 | -0.79% | Truist Securities | → $225 | Upgrades | Hold → Buy |
| 11/09/2020 | -13.57% | BMO Capital | $181 → $196 | Maintains | Market Perform |
| 11/06/2020 | -2.99% | Barclays | $210 → $220 | Maintains | Overweight |
| 11/06/2020 | -14.02% | Credit Suisse | $190 → $195 | Maintains | Neutral |
| 11/06/2020 | -4.31% | Morgan Stanley | $209 → $217 | Maintains | Overweight |
| 10/20/2020 | -7.84% | Morgan Stanley | $200 → $209 | Maintains | Overweight |
| 08/06/2020 | -7.4% | Barclays | $165 → $210 | Maintains | Overweight |
| 08/06/2020 | -28.13% | UBS | $159 → $163 | Maintains | Sell |
| 08/06/2020 | -11.81% | Baird | $180 → $200 | Maintains | Outperform |
| 08/06/2020 | -20.19% | BMO Capital | $156 → $181 | Maintains | Market Perform |
| 08/06/2020 | -11.81% | Morgan Stanley | $191 → $200 | Maintains | Overweight |
| 08/05/2020 | -16.22% | Credit Suisse | $160 → $190 | Maintains | Neutral |
| 07/10/2020 | -15.78% | Morgan Stanley | $178 → $191 | Maintains | Overweight |
| 07/08/2020 | -29.89% | UBS | $148 → $159 | Maintains | Sell |
| 05/07/2020 | -31.21% | BMO Capital | $165 → $156 | Maintains | Market Perform |
| 05/07/2020 | -25.04% | Baird | $163 → $170 | Maintains | Outperform |
| 05/07/2020 | -34.74% | UBS | $138 → $148 | Maintains | Sell |
| 05/07/2020 | -16.22% | Wells Fargo | $175 → $190 | Maintains | Overweight |
| 05/07/2020 | -21.51% | Morgan Stanley | $181 → $178 | Maintains | Overweight |
| 04/22/2020 | -20.19% | Morgan Stanley | $176 → $181 | Maintains | Overweight |
| 04/20/2020 | -29.45% | B of A Securities | $176 → $160 | Maintains | Neutral |
| 04/09/2020 | -27.24% | Barclays | $170 → $165 | Maintains | Overweight |
| 04/06/2020 | -39.15% | UBS | $151 → $138 | Maintains | Sell |
| 03/31/2020 | -36.5% | RBC Capital | → $144 | Initiates Coverage On | → Sector Perform |
| 03/20/2020 | -22.83% | Wells Fargo | $195 → $175 | Maintains | Overweight |
| 03/10/2020 | -22.39% | Morgan Stanley | $180 → $176 | Maintains | Overweight |
| 02/20/2020 | -17.1% | JP Morgan | $165 → $188 | Maintains | Overweight |
| 02/20/2020 | -15.78% | Baird | $184 → $191 | Maintains | Outperform |
| 02/20/2020 | -20.63% | Morgan Stanley | $176 → $180 | Maintains | Overweight |
| 02/20/2020 | -33.42% | UBS | $148 → $151 | Maintains | Sell |
| 02/19/2020 | -28.57% | Deutsche Bank | $154 → $162 | Maintains | Hold |
| 01/22/2020 | -18.87% | Baird | $165 → $184 | Maintains | Outperform |
| 01/22/2020 | -31.65% | Credit Suisse | $150 → $155 | Maintains | Neutral |
| 01/07/2020 | -22.39% | Morgan Stanley | $162 → $176 | Upgrades | Equal-Weight → Overweight |
| 11/22/2019 | -23.28% | Jefferies | → $174 | Initiates Coverage On | → Buy |
| 11/04/2019 | -41.8% | UBS | $131 → $132 | Maintains | Sell |
| 10/31/2019 | -28.57% | Morgan Stanley | $164 → $162 | Maintains | Equal-Weight |
| 10/10/2019 | -27.68% | Morgan Stanley | $163 → $164 | Maintains | Equal-Weight |
| 09/23/2019 | -26.8% | Keefe, Bruyette & Woods | → $166 | Initiates Coverage On | → Market Perform |
| 07/31/2019 | -31.65% | B of A Securities | $146 → $155 | Maintains | Neutral |
| 07/10/2019 | -45.32% | UBS | $119 → $124 | Maintains | Sell |
| 05/02/2019 | -47.53% | UBS | $111 → $119 | Maintains | Sell |
| 04/09/2019 | -51.05% | UBS | $106 → $111 | Maintains | Sell |
| 03/12/2019 | -53.26% | UBS | $100 → $106 | Maintains | Sell |
| 01/08/2019 | -55.91% | UBS | $104 → $100 | Maintains | Sell |
What is the target price for Verisk Analytics (VRSK)?
The latest price target for Verisk Analytics (NASDAQ: VRSK) was reported by Raymond James on November 2, 2023. The analyst firm set a price target for $260.00 expecting VRSK to rise to within 12 months (a possible 14.65% upside). 45 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Verisk Analytics (VRSK)?
The latest analyst rating for Verisk Analytics (NASDAQ: VRSK) was provided by Raymond James, and Verisk Analytics maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Verisk Analytics (VRSK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Verisk Analytics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Verisk Analytics was filed on November 2, 2023 so you should expect the next rating to be made available sometime around November 2, 2024.
Is the Analyst Rating Verisk Analytics (VRSK) correct?
While ratings are subjective and will change, the latest Verisk Analytics (VRSK) rating was a maintained with a price target of $255.00 to $260.00. The current price Verisk Analytics (VRSK) is trading at is $226.79, which is out of the analyst's predicted range.